Hydrogel spacing for radiotherapy of prostate cancer: A review of the literature

Urology Practice

Volumn 1, Issue 2, 2014, Pages 79-85

  Mahal, Brandon A ^b   O'Leary, Michael P ^a   Nguyen, Paul L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Iatrogenic disease; Prostate; Prostatic neoplasms; Radiotherapy; Rectum

Indexed keywords

HYALURONIC ACID; MACROGOL;

ARTICLE; BRACHYTHERAPY; CANCER RADIOTHERAPY; DOSIMETRY; GASTROINTESTINAL TOXICITY; HUMAN; HYDROGEL; HYDROGEL ORGAN SPACER; INTENSITY MODULATED RADIATION THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; RADIATION EXPOSURE; RECTAL TOXICITY; TRANSRECTAL ULTRASONOGRAPHY;

EID: 84904244424     PISSN: 23520779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urpr.2014.03.004     Document Type: Article

References (30)

1. Siegel R., Ma J., Zou Z., et al. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9.
2. Widmark A., Klepp O., Solberg A., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009, 373:301.
3. Etzioni R., Gulati R., Tsodikov A., et al. The prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer 2012, 118:5955.
4. Ghilezan M.J., Jaffray D.A., Siewerdsen J.H., et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005, 62:406.
5. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 2008, 70:67.
6. Zietman A.L., Bae K., Slater J.D., et al. Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from Proton Radiation Oncology Group/American College of Radiology 95-09. JClin Oncol 2010, 28:1106.
7. Zelefsky M.J., Fuks Z., Hunt M., et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. JUrol 2001, 166:876.
8. Zelefsky M.J., Fuks Z., Hunt M., et al. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 2002, 53:1111.
9. Hunter G.K., Reddy C.A., Klein E.A., et al. Long-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer. Prostate Cancer 2012, 2012:853487.
10. Smeenk R.J., van Lin E.N. Application of anorectal sparing devices in prostate radiotherapy. Radiother Oncol 2013, 106:155.
11. Smeenk R.J., Teh B.S., Butler E.B., et al. Is there a role for endorectal balloons in prostate radiotherapy? A systematic review. Radiother Oncol 2010, 95:277.
12. Melchert C., Gez E., Bohlen G., et al. Interstitial biodegradable balloon forreduced rectal dose during prostate radiotherapy: results of a virtual planning investigation based on the pre- and post-implant imaging data of an international multicenter study. Radiother Oncol 2013, 106:210.
13. Prada P.J., Fernandez J., Martinez A.A., et al. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients. Int J Radiat Oncol Biol Phys 2007, 69:95.
14. Pinkawa M., Corral N.E., Caffaro M., et al. Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancer. Radiother Oncol 2011, 100:436.
15. Hatiboglu G., Pinkawa M., Vallee J.P., et al. Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy. BJU Int 2012, 110:E647.
16. Pinkawa M., Klotz J., Djukic V., et al. Learning curve in the application of ahydrogel spacer to protect the rectal wall during radiotherapy of localized prostate cancer. Urology 2013, 82:963.
17. Beydoun N., Bucci J.A., Chin Y.S., et al. First report of transperineal polyethylene glycol hydrogel spacer use to curtail rectal radiation dose after permanent iodine-125 prostate brachytherapy. Brachytherapy 2013, 12:368.
18. Nguyen P.L., Devlin P.M., Beard C.J., et al. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature. Brachytherapy 2013, 12:77.
19. Mahal BM, Ziehr DR, Hyatt AS etal: Use of a rectal spacer with LDR brachytherapy for treatment of prostate cancer in previously irradiated patients: initial experience and short term results. Unpublished data.
20. Noyes W.R., Hosford C.C., Schultz S.E. Human collagen injections to reduce rectal dose during radiotherapy. Int J Radiat Oncol Biol Phys 2012, 82:1918.
21. Daar E., King L., Nisbet A., et al. Viscosity changes in hyaluronic acid: irradiation and rheological studies. Appl Radiat Isot 2010, 68:746.
22. Uhl M., van Triest B., Eble M.J., et al. Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: results of a multi-institutional phase II trial. Radiother Oncol 2013, 106:215.
23. Wilder R.B., Barme G.A., Gilbert R.F., et al. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer. Int JRadiat Oncol Biol Phys 2010, 77:824.
24. Prada P.J., Gonzalez H., Menendez C., et al. Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients. Brachytherapy 2009, 8:210.
25. Wilder R.B., Barme G.A., Gilbert R.F., et al. Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy. Brachytherapy 2011, 10:44.
26. Song D.Y., Herfarth K.K., Uhl M., et al. Amulti-institutional clinical trial of rectal dose reduction via injected polyethylene-glycol hydrogel during intensity modulated radiation therapy for prostate cancer: analysis of dosimetric outcomes. Int J Radiat Oncol Biol Phys 2013, 87:81.
27. Susil R.C., McNutt T.R., DeWeese T.L., et al. Effects of prostate-rectum separation on rectal dose from external beam radiotherapy. Int J Radiat Oncol Biol Phys 2010, 76:1251.
28. Pinkawa M., Djukic V., Holy R. Application of a spacer between prostate and anterior rectal wall to optimize radiotherapy of localized prostate cancer. Strahlenther Onkol 2011, 187:42.
29. Pinkawa M., Piroth M.D., Holy R., et al. Spacer stability and prostate position variability during radiotherapy for prostate cancer applying a hydrogel to protect the rectal wall. Radiother Oncol 2013, 106:220.
30. Pinkawa M., Piroth M.D., Holy R. Quality of life after intensity-modulated radiotherapy for prostate cancer with a hydrogel spacer. Matched-pair analysis. Strahlenther Onkol 2012, 188:917.